betamethasone-17,21-dipropionate has been researched along with oxytetracycline, anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emgård, P; Hellström, S; Holm, S | 1 |
| Emgård, P; Hellström, S | 1 |
1 trial(s) available for betamethasone-17,21-dipropionate and oxytetracycline, anhydrous
| Article | Year |
|---|---|
A group III steroid solution without antibiotic components: an effective cure for external otitis.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Ear Canal; Female; Humans; Hydrocortisone; Male; Middle Aged; Otitis Externa; Oxytetracycline; Polymyxin B; Treatment Outcome | 2005 |
1 other study(ies) available for betamethasone-17,21-dipropionate and oxytetracycline, anhydrous
| Article | Year |
|---|---|
External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Betamethasone; Candidiasis; Colony-Forming Units Assay; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ear Canal; Hydrocortisone; Male; Otitis Externa; Oxytetracycline; Polymyxin B; Pseudomonas Infections; Rats; Treatment Outcome | 2005 |